Sun Pharma

Pharma Stocks Surge After US Senate Passes Biosecure Act

Pharma stocks gained momentum on December 19 as the US Senate approved the Biosecure Act, a key provision within the fiscal 2026 National Defense Authorization Act (NDAA). This move, aimed at limiting certain Chinese biotech companies from receiving federal funding, sparked a positive reaction ac...

Q2 Results 2025 Today: Sun Pharma, Grasim, Britannia, Aurobindo Pharma & Delhivery Set to Announce September Quarter Earnings

The mid-week session on Dalal Street brings a heavy earnings lineup, even though the market remains shut today.A long list of companies is preparing to release their Q2 results 2025, turning the day into one of the busiest moments of the season.What makes the day interesting is the concentration ...